Eli Lilly CEO: Our pill supply can 'reach the planet'

Eli Lilly Chair & CEO Dave Ricks tells CNBC’s Angelica Peebles that with the approval of the company’s GLP-1 pill, orforglipron, they already have the scale necessary to supply the medicine to the globe. Ricks says that while 1 in 10 Americans are currently using a GLP-1, in China only 0.5% of the population has tried one, pointing to a large untapped market opportunity internationally. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/42d859g

» Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision
» Subscribe to CNBC: https://cnb.cx/SubscribeCNBC
» Watch CNBC on the go with CNBC+: https://www.cnbc.com/WatchCNBCPlus

Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.

Connect with CNBC News Online
Get the latest news: http://www.cnbc.com/
Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC
Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC
Follow CNBC News on Facebook: https://cnb.cx/LikeCNBC
Follow CNBC on Threads: https://cnb.cx/threads
Follow CNBC News on X: https://cnb.cx/FollowCNBC
Follow CNBC on WhatsApp: https://cnb.cx/WhatsAppCNBC

https://www.cnbc.com/select/best-credit-cards/

#CNBC
#cnbctv

Видео Eli Lilly CEO: Our pill supply can 'reach the planet' канала CNBC Television